Mature dendritic cells boost functionally superior CD8(+) T-cell in humans without foreign helper epitopes
about
Dendritic cell vaccines for brain tumorsDirect Delivery of Antigens to Dendritic Cells via Antibodies Specific for Endocytic Receptors as a Promising Strategy for Future TherapiesThe Role of Dendritic Cells in Fibrosis Progression in Nonalcoholic Fatty Liver DiseaseMetastatic renal cell carcinoma: update on epidemiology, genetics, and therapeutic modalitiesTwelve-year survival and immune correlates in dendritic cell-vaccinated melanoma patients.A double-blind randomized phase I clinical trial targeting ALVAC-HIV vaccine to human dendritic cells.Dendritic cell-derived exosomes promote natural killer cell activation and proliferation: a role for NKG2D ligands and IL-15Ralpha.Human Langerhans cells induce distinct IL-22-producing CD4+ T cells lacking IL-17 production.Linear and branched glyco-lipopeptide vaccines follow distinct cross-presentation pathways and generate different magnitudes of antitumor immunityA randomized therapeutic vaccine trial of canarypox-HIV-pulsed dendritic cells vs. canarypox-HIV alone in HIV-1-infected patients on antiretroviral therapyDownregulation of PTP1B and TC-PTP phosphatases potentiate dendritic cell-based immunotherapy through IL-12/IFNγ signaling.Mature dendritic cells infected with canarypox virus elicit strong anti-human immunodeficiency virus CD8+ and CD4+ T-cell responses from chronically infected individuals.Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance.beta-Glucan oligosaccharide enhances CD8(+) T cells immune response induced by a DNA vaccine encoding hepatitis B virus core antigen.Humoral and cell-mediated adaptive immune responses are required for protection against Burkholderia pseudomallei challenge and bacterial clearance postinfection.New methods for assessing T-cell responses.T cells from the tumor microenvironment of patients with progressive myeloma can generate strong, tumor-specific cytolytic responses to autologous, tumor-loaded dendritic cells.Human immunodeficiency virus pathogenesis and prospects for immune control in patients with established infection.Increased macrophage infection upon subcutaneous inoculation of rhesus macaques with simian immunodeficiency virus-loaded dendritic cells or T cells but not with cell-free virus.Strategies for designing and optimizing new generation vaccines.Efficiency of dendritic cell vaccination against B16 melanoma depends on the immunization route.Human liver dendritic cells promote T cell hyporesponsiveness.Results of a phase 1 study utilizing monocyte-derived dendritic cells pulsed with tumor RNA in children and young adults with brain cancer.Expression of CD1a and Type-1 Polarization Are Dissociated in Human Monocyte-Derived Dendritic CellsCharacterization of canine monocyte-derived dendritic cells with phenotypic and functional differentiationHow much help does a vaccine-induced T-cell response need?Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells.Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein.Expansion of melanoma-specific cytolytic CD8+ T cell precursors in patients with metastatic melanoma vaccinated with CD34+ progenitor-derived dendritic cells.Immunotherapy for melanoma: current status and perspectives.Dendritic cells strongly boost the antitumor activity of adoptively transferred T cells in vivo.Human papillomavirus type 16 and 18 E7-pulsed dendritic cell vaccination of stage IB or IIA cervical cancer patients: a phase I escalating-dose trial.Adenovirus MART-1-engineered autologous dendritic cell vaccine for metastatic melanoma.Mobilization of dendritic cell precursors in patients with cancer by flt3 ligand allows the generation of higher yields of cultured dendritic cells.Dendritic cell-based immunotherapy for malignant glioma.Dendritic cells: at the clinical crossroads.Dendritic cell immunotherapy for HIV infection: from theory to reality.Dendritic cell preparation for immunotherapeutic interventions.Crosstalk between dendritic cell subsets and implications for dendritic cell-based anticancer immunotherapy.Dendritic cell-based vaccine for the treatment of malignant glioma: a systematic review.
P2860
Q24641823-FF01A281-3D75-4DAF-AB67-28C2E9F1EFBFQ26752558-8C508868-322A-42A7-982C-694F60EF29C4Q26784452-4F1E10FC-C7D7-4399-8BEA-52EED325A935Q26852437-C9C6CB07-C861-4D21-B340-8890EC45F863Q30846001-74BEDC8B-4658-4992-BBED-DA8D1FA42D89Q31031447-C017C982-55AD-4127-A907-C4CBC7F03FB0Q33421740-A85FF0F5-0AB3-480F-8E12-098F9232FA82Q33564666-11C5EB90-FE0C-4D5E-B312-C8C0E4442964Q33614657-3B095B43-35E5-4F8D-9675-6550912065B9Q33645564-535A34B7-0FF4-4D26-A857-8530CD4607E6Q33839267-6002F82C-FE64-4BBA-B77B-C9F8E23EFC00Q33850510-E9E64A0A-F923-4F89-B8FD-612D8675D597Q33897693-9AA57CE2-BF1A-4BDC-AA50-5D16BFDAED8CQ33960217-337B964F-B743-478B-AA67-A68C3FFB89CEQ34034124-7C85282E-4916-41B8-B1B3-18C2EE0F3239Q34076691-29916512-2DAD-435E-AEB1-FE7655B65F3BQ34191186-314A29ED-ADF2-44CB-B572-BD9D68797E8EQ34255654-28C6927D-C41C-470B-B7C0-343465FCCAB4Q34347386-FF613391-A51C-4459-BF3D-85725DCC2555Q34572198-CE7A31B4-1E22-4504-89EC-ECD43143F8E5Q35224721-3CF27F40-E3D0-4080-AEEC-771B60183986Q35661559-7EC6FC66-E224-4786-B812-0EF12B43550AQ35800798-3F69DB82-8A3F-4252-A3B5-F72BE02C1EDBQ35804487-EEFA8EBC-9C79-4385-9156-ACB2156EAE8EQ35856643-8065B8F8-CF34-4D2B-8B31-029E726577C8Q36013867-598B9EF9-0DAF-46B8-A387-CE06FAE45F5CQ36369028-B57BA793-8058-4C8E-8575-AC7BE255C878Q36371349-D812A9B0-465B-449D-8C6A-47634CFB3409Q36399108-1AD79DAE-3CC3-4BEE-8101-3A0B079C1753Q36453216-0183A448-0507-48FF-B325-093A0CE45991Q36456769-4010BCF9-935E-4A8E-BFF3-95ED9EEF2C44Q36483341-108CDB72-2A5C-4BB1-ACA1-B4B747201559Q36834545-6ED96D44-7731-4030-BCFA-2C54A63B1736Q36908551-33D7F327-51A1-4956-9888-38AD900EDC17Q37084101-EDE80547-95BE-474E-89E1-7A891E8D6151Q37176078-A287BAFA-235A-4DBC-9102-F27BABFBECACQ37773251-AE72D604-CD92-4923-AFBE-0644BB656A4EQ37773266-634099C8-1CEE-4EBF-82E6-F6E89C11D537Q38206571-8B9E2C2E-56B1-4152-AC32-AD7C7527C2C1Q38254629-53C8BBC7-B846-4AAF-BF25-7C86CB1DF3A3
P2860
Mature dendritic cells boost functionally superior CD8(+) T-cell in humans without foreign helper epitopes
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2000
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mature dendritic cells boost functionally superior CD8
@nl
Mature dendritic cells boost f ...... ithout foreign helper epitopes
@en
type
label
Mature dendritic cells boost functionally superior CD8
@nl
Mature dendritic cells boost f ...... ithout foreign helper epitopes
@en
prefLabel
Mature dendritic cells boost functionally superior CD8
@nl
Mature dendritic cells boost f ...... ithout foreign helper epitopes
@en
P2093
P2860
P356
P1476
Mature dendritic cells boost f ...... ithout foreign helper epitopes
@en
P2093
J Krasovsky
M V Dhodapkar
N Bhardwaj
R M Steinman
P2860
P304
P356
10.1172/JCI9051
P407
P577
2000-03-01T00:00:00Z